The Neoadjuvant Administration of PD-1 Inhibitor plus Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous-Cell Carcinoma

Table 4

ypTNM stage.

ypTNM stage	Locally advanced ESCC patients (N = 25)
ypT0N0M0, no. (%)	13 (52.0)
ypT0N1M0, no. (%)	1 (4.0)
ypT1bN1M0, no. (%)	1 (4.0)
ypT1bN3M0, no. (%)	1 (4.0)
ypT2N0M0, no. (%)	2 (8.0)
ypT3N0M0, no. (%)	3 (12.0)
ypT3N2M0, no. (%)	4 (16.0)

ypTNM, post neoadjuvant pathologic tumor-node-metastasis; ESCC, esophageal squamous-cell carcinoma.